124I-mIBG
- Generic Name
- 124I-mIBG
A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 36
- Registration Number
- NCT02043899
- Locations
- 🇬🇧
University College London Hospital, London, United Kingdom
🇬🇧Royal Marsden Hospital, Sutton, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath